Hydrogel microneedle patch with myocardial stem cell transferring function
Through the hydrogel microneedle patch device, the gradient dissolution channel and concave substrate design of hollow microneedle and chitosan materials is used to solve the problem of low retention and survival rate of cardiomyocyte stem cell transport, and achieve efficient myocardial muscle The improvement of stem cell delivery and therapeutic effects, the materials are harmless to the human body and metabolically excreted.
Patent Information
- Application Number
- CN202410953807.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-08
AI Technical Summary
Existing myocardial stem cell transport methods, such as intramuscular injection, make it difficult to effectively retain stem cells and survive in designated areas of the myocardium, resulting in poor treatment results.
Using hydrogel microneedle patch device, designed through hollow microneedle and chitosan materials, provides gradient dissolution channels and concave substrates to ensure stable connection and precise delivery of stem cells, and to the adhesion and biologicity of the encapsulated membrane. Degradability improves adhesion and retention.
It significantly improves the retention and survival rate of myocardial stem cells, enhances the therapeutic effect of myocardial infarction area, and the material is non-toxic to the human body and is excreted through metabolic hydrolysis.
Smart Images

Figure CN118903671A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of microneedle patch devices, and more specifically, relates to a hydrogel microneedle patch with the function of transporting myocardial stem cells. Background Art
[0002] Stem cells are defined as undifferentiated cells with the potential to self-renew and differentiate into one or more specialized cells. This means that stem cells can undergo multiple cell divisions and maintain the ability to differentiate. Adult stem cells are derived from different organs, including muscle, bone marrow, blood, epidermis, brain, liver, and adipose tissue.
[0003] The self-repair ability of myocardial cells after myocardial infarction is extremely limited. At this time, the heart cannot effectively transport blood to the whole body. As the blood supply to the myocardium decreases, the lack of oxygen and nutrients in the myocardial cells will quickly lead to cell death. It can only be treated with lifelong drug assistance or even by implanting mechanical assistance devices. However, in recent years, stem cell research has brought new hope for the repair of necrotic myocardium. The most effective method at present is to transport stem cells to the myocardium through a combination of patches and microneedles to repair the necrotic area of the myocardium.
[0004] Stem cells are a type of cell with the ability of self-renewal and multidirectional differentiation, which can differentiate into different types of cells, including cardiomyocytes. Scientists have discovered that there are stem cells from a variety of sources in the human body, such as adipose stem cells and bone marrow stem cells, which provide a feasible source of cells for patch stem cell-assisted myocardial therapy. Secondly, the progress of tissue engineering also plays a key role in patch stem cell-assisted myocardial therapy. Tissue engineering refers to the combination of cells, biological scaffolds, and growth factors to construct functional tissues or organs. In patch stem cell-assisted myocardial therapy, scientists use biological scaffolds and suitable cell culture conditions to provide an environment conducive to stem cell growth and differentiation. These scaffolds can simulate the structure and properties of cardiac tissue and promote the localization of patch stem cells to damaged myocardial areas. In addition, the study of cardiac pathology also provides a theoretical and practical basis for patch stem cell-assisted myocardial therapy. Cardiac pathology is a discipline that studies the mechanisms and pathological changes of heart disease. By gaining a deeper understanding of cardiac pathology, scientists can better understand the process of myocardial injury and regeneration, and provide guidance for patch stem cell-assisted myocardial therapy.
[0005] Microneedles are a type of micro-needle device arranged in an array, usually with a diameter of tens to hundreds of microns. They are developed from micro-nano processing technology and are generally made of materials such as metals or polymers. Microneedle technology has great potential for application in the auxiliary treatment of cardiovascular diseases. The implantation of microneedle patches can repair the site of cardiac lesions, improve the fit and biocompatibility of the myocardium, and release drugs directly into the diseased tissue, maximizing the effect of drugs in the affected area, and reducing the time and dosage of auxiliary treatment to avoid possible adverse reactions. This is of great value for the auxiliary treatment of cardiovascular diseases such as myocardial infarction and heart failure.
[0006] At present, the commonly used method of transporting stem cells is intramyocardial injection. The process of adjuvant therapy is to transplant healthy cardiomyocytes into the native myocardium for fusion to form new cardiomyocytes. Intramyocardial injection is a route of administration of stem cells directly into myocardial tissue. The method is minimally invasive thoracoscopic surgery or catheter-based needle injection. Intramyocardial injection has obvious disadvantages, such as transporting stem cells to remote areas, or ischemic and hypoxic infarct areas, and it is difficult to bring them to the designated area of cells, which makes the retention rate and survival rate of stem cells low, reducing the effect of adjuvant therapy.
[0007] Patch-based delivery of stem cells to the myocardium refers to the generation of tissue structures in vitro and then transplantation into the body. Patch stem cells are derived from the patient himself or provided by a donor. After culture and diffusion, they are carried by a patch. Patch stem cells are usually delivered to the patient's myocardial area through microneedles, catheters, and other special delivery systems so that the stem cells can play a role. Once the patch stem cells are located in the heart tissue, they will gradually differentiate into cardiomyocytes, vascular endothelial cells, and other cardiovascular-related cells. These newly generated cells can promote the repair and regeneration of myocardial tissue. They can fuse into damaged tissue and increase the number of cardiomyocytes; at the same time, they can also secrete growth factors and other cell signaling molecules to stimulate the growth and regeneration of surrounding tissues. In addition, patch stem cells may also have a protective effect on damaged myocardial tissue by regulating immune responses, reducing inflammation, and inhibiting cell apoptosis. Summary of the invention
[0008] One of the technical purposes of the present invention is to improve the retention rate and survival rate of stem cells in myocardial tissue and to transport as many myocardial stem cells as possible into the myocardium. The hydrogel microneedle patch for transporting myocardial stem cells has hollow microneedles in structure. Through this structure, the microneedle patch can be tightly attached to the myocardial surface to provide a stable connection during the entire myocardial stem cell delivery process, ensuring that the internal myocardial stem cells can fully enter the myocardium and be accurately delivered.
[0009] The second technical purpose of the present invention is to use chitosan to make hollow microneedles to form a gradual dissolution channel, which is more conducive to the delivery of myocardial stem cells. Chitosan is easily soluble in water and can be metabolized and absorbed by the human body. The chitosan hollow microneedles will gradually dissolve, and more and larger channels will be formed at this time, allowing myocardial stem cells to enter the myocardium autonomously, accelerating the transport speed. Subsequently, the substrate made of chitosan will also gradually dissolve, and the transport efficiency will reach the maximum at this time; through this gradual dissolution channel design, the release of myocardial stem cells is continuous and gradual, ensuring the stability and efficiency of delivery.
[0010] The third technical purpose of the present invention is to design the substrate into a concave structure similar to a "concave lens" with a certain concave curvature. Taking into account that the surface of the myocardium is not flat and some myocardial tissues have small protrusions, the contact area between the hollow microneedles and the myocardial surface is increased, and the microneedles are gathered in a fixed area in a targeted manner for point-to-point delivery.
[0011] The fourth technical purpose of the present invention is to provide an operation method of a hydrogel microneedle patch device with the function of transporting myocardial stem cells. Based on the structural characteristics, mechanical properties and functional characteristics of the hydrogel microneedle patch device with the function of transporting myocardial stem cells, the targeted delivery of myocardial stem cells is achieved and the delivery efficiency is guaranteed under the premise of safe and stable transportation.
[0012] The technical problem to be solved by the present invention is to provide a hydrogel microneedle patch that can encapsulate stem cells as a myocardial stem cell carrier, which can transport myocardial stem cells and transport them to a designated location of the myocardium, thereby increasing the attachment rate of the microneedle patch on the myocardial surface, and increasing the retention rate and growth rate of myocardial stem cells, significantly enhancing the transplantation of infarcted myocardial cells and the application effect of auxiliary treatment of myocardial infarction. During use, it is non-toxic and harmless to the human body, and after use, it is excreted from the body through metabolic hydrolysis.
[0013] In order to solve the above technical problems, the technical solution adopted by the present invention is:
[0014] A hydrogel microneedle patch with the function of transporting myocardial stem cells, comprising:
[0015] A stem cell lysis pool, the inner wall of which is provided with hydrogel, and the hydrogel is used to encapsulate myocardial stem cells and nutrients that maintain the survival of myocardial stem cells;
[0016] A plurality of hollow microneedles are arranged in a circle on the top of the stem cell lysate pool and are perpendicular to the substrate of the stem cell lysate pool; the substrate is a concave structure, and the plurality of hollow microneedles arranged in a circle are gathered at one point, providing a channel for myocardial stem cells and nutrients to enter the myocardium;
[0017] The encapsulation film is arranged around the top of the stem cell lysate pool to encapsulate and wrap the top of the stem cell lysate pool and the hollow microneedles as a whole, and provide sufficient adsorption force for the hydrogel microneedle patch to ensure that the hydrogel microneedle patch will not fall off or be contaminated during operation, and has excellent wet adhesion and electrical conductivity similar to that of the myocardium.
[0018] Preferably, the stem cell lysis pool includes a substrate, an enclosure and a bottom plate, the enclosure is erected to form a circle; the substrate is arranged on the top of the enclosure, and the bottom plate is arranged at the bottom of the enclosure; the hollow microneedles are arranged in a circle on the substrate; and the packaging film is connected around the enclosure to encapsulate and wrap the hollow microneedles and the substrate.
[0019] Preferably, the hollow microneedle is a shell-like porous structure made of chitosan, and each hollow microneedle is perpendicular to the substrate; the substrate is a plate-like structure made of chitosan. Considering that the myocardial surface is not flat and some myocardial tissues have small protrusions, the substrate is designed to have a certain concave arc similar to a "concave lens" concave structure, which increases the contact area between the hollow microneedle and the myocardial surface, and gathers in a fixed area in a targeted manner for point-to-point delivery. In addition, the hollow microneedle is arranged in a circular manner, and each hollow microneedle is perpendicular to the inner side of the concave substrate, so that the state presented by several hollow microneedles is the effect of gathering at "one point"; the enclosure is a cylindrical structure made of chitosan, and the bottom of the inner wall of the stem cell hydrogel adopts a circular chamfer transition to form an arc chamfered inner wall to reduce the residual myocardial cell solution. The hollow microneedle is made of chitosan to make the shell. As time goes by, the chitosan microneedle will gradually melt to form a larger channel, greatly increasing the speed at which myocardial stem cells enter the myocardium.
[0020] Preferably, in order to make the base plate and the enclosure better fit together, the connection between the enclosure and the base plate is set as a stepped connection to provide better support for the base plate.
[0021] Preferably, the height of the hollow microneedle is 0.5 to 4 mm, the needle body is conical, triangular pyramidal or quadrangular pyramidal, the needle tip diameter is 50 to 100 μm, and the bottom size of the needle body is 200 to 500 μm; the porous structure on the needle body is composed of 20 to 50 μm array holes distributed on the side wall of the shell-like structure, and the shell wall thickness is 500 to 800 μm.
[0022] Preferably, the substrate and the surrounding plate are integrally formed with the hollow microneedle; the thickness of the substrate is 300 to 500 μm; the thickness of the surrounding plate is 500 to 1000 μm.
[0023] Preferably, the encapsulation film is a petal-shaped structure with a thick middle and thin sides, made of a hydrophilic hydrogel material with excellent wet adhesion and electrical conductivity similar to that of the myocardium. The petal-shaped structure can completely cover the stem cell lysate pool and the hollow microneedles. The encapsulation film is pre-set with built-in stress inside to make the encapsulation film airtight. The encapsulation film is connected to the bottom plate, wrapping the entire patch device inside, and has a certain protective ability to ensure that the microneedle patch is not contaminated. It also has good hydrophilicity, and the film connection can be quickly dissolved in an appropriate solution, and then the entire patch is unfolded.
[0024] A method for operating a hydrogel microneedle patch with the function of transporting myocardial stem cells comprises the following steps: a certain internal stress is preset inside a sealed packaging film to make the packaging film airtight. The packaging film is connected to a substrate to completely cover the stem cell molten pool and hollow microneedles. After the hydrogel microneedle patch is placed in physiological saline, it gradually dissolves from the apex and valve flanks and unfolds to expose the internal microneedle structure. The packaging film is composed of pyrrole-terminated poly (β-amino acid) and gelatin; the gradually dissolved hydrogel valve is adsorbed on the myocardial surface, and the hollow microneedle is penetrated into the myocardial surface based on the adhesion pressure to form a minimally invasive channel; the myocardial stem cells are allowed to enter the myocardium from the hollow microneedle end, so as to achieve the purpose of transporting myocardial stem cells and prolong the residence time of the hydrogel microneedle patch on the myocardial surface based on the packaging film that has not been completely melted;
[0025] The beneficial effects of adopting the above technical solution are:
[0026] (1) The present invention has a novel structure and applies microneedle technology to the field of auxiliary treatment of heart diseases. In particular, a hydrogel microneedle device is prepared, which can transport myocardial stem cells and effectively transport stem cells to a designated location of the myocardium to achieve the purpose of auxiliary treatment of myocardial infarction;
[0027] (2) The bioengineering materials hydrogel and chitosan used in the present invention are non-toxic and harmless to the human body, and after use, they are excreted from the body through metabolic hydrolysis, and do not require minimally invasive surgery to remove them;
[0028] (3) The present invention can play an obvious auxiliary treatment effect. When using the device, the adhesion rate of the microneedle patch on the myocardial surface can be improved, and the retention rate and growth rate of myocardial stem cells can be improved.
[0029] (4) The present invention uses the latest microneedle technology to deliver stem cells, which is better than myocardial injection;
[0030] (5) The present invention is safe and effective, suitable for people suffering from myocardial infarction, and can be promoted and used on a larger scale. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1It is a schematic diagram of the structures of various parts of a hydrogel microneedle patch device for transporting cardiomyocyte function of the present invention.
[0032] Figure 2 It is a cross-sectional schematic diagram of the structural structure of each part of the hydrogel microneedle patch device for transporting cardiomyocyte function.
[0033] Figure 3 Schematic cross-section of a hydrogel microneedle patch device for transporting cardiomyocyte function.
[0034] Figure 4 is a schematic cross-sectional view of a hydrogel microneedle patch device.
[0035] Figure 5 It is a top view schematic diagram of the hydrogel microneedle patch device placed in physiological saline and the films on both sides dissolve.
[0036] In the figure: 1. stem cell lysate pool; 11. substrate; 12. enclosure; 13. bottom plate; 14. stem cell hydrogel; 2. hollow microneedles; 3. encapsulation film. DETAILED DESCRIPTION
[0037] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0038] like Figure 3 As shown, the patch device includes a stem cell lysate pool 1, a hollow microneedle 2 and an encapsulation film 3, and the stem cell lysate pool 1 and the hollow microneedle 2 are formed in one piece. The stem cell lysate pool 1 includes a substrate 11, a panel 12, a bottom plate 13, and a stem cell hydrogel 14. The substrate 11 is a plate-like structure made of chitosan, and the panel 12 is a cylindrical structure made of chitosan. The substrate 11 is arranged on the top of the panel 12, and the bottom plate 13 is arranged at the bottom of the panel. The stem cell hydrogel 14 is evenly applied to the stem cell lysate pool. The substrate 11, the panel 12, and the stem cell hydrogel 14 form a cavity. The stem cell hydrogel is evenly applied to the inner wall of the stem cell lysate pool 1, which is mainly used to carry myocardial stem cells and their nutrients. This structure can transport more myocardial stem cells. The present invention uses hydrogel to wrap myocardial stem cells, which has great advantages because the hydrogel has good encapsulation biological cell activity, and its degradation products are non-toxic amino acids, etc. In summary, the main function of the stem cell hydrogel is to encapsulate myocardial stem cells and their nutrients to achieve maximum cell activity.
[0039] The hollow microneedles 2 are distributed in a circle on the substrate 11. The hollow microneedles 2 are shell-like porous structures made of chitosan. The height of the hollow microneedles 2 is 0.5-4 mm. The needle body is conical, triangular pyramidal or quadrangular pyramidal. The diameter of the needle tip is 50-100 μm, and the size of the bottom of the needle body is 200-500 μm. The porous structure on the needle body is composed of 20-50 μm array holes, which are distributed on the side wall of the shell structure, and the shell wall thickness is 500-800 μm. It should be noted that the maximum height of the needle body is 4 mm, the maximum diameter of the needle tip is 100 μm, and the maximum diameter of the bottom of the needle body is 500 μm.
[0040] The encapsulation film 3 made of hydrogel is composed of four-petal hydrogel, which can completely wrap the internal hollow microneedle patch. The hydrogel has the characteristics of being thick in the middle and thin on both sides. A certain built-in stress is preset inside the airtight encapsulation film 3, so that the encapsulation film 3 is airtight. The encapsulation film 3 should be connected to the chitosan substrate. When the device is placed in physiological saline, it begins to dissolve and unfold from the apex and the flanks of the valve, exposing the internal structure. The hydrogel encapsulation film is composed of pyrrole-terminated poly (β-amino acid) and gelatin, wherein the poly (β-amino acid) is a controllable biodegradable material, and its degradation products are non-toxic amino acids, diols and acrylic acid. Due to its excellent adhesion ability, the hydrogel encapsulation film has an adhesion strength of about 22.2kPa to myocardial tissue. In summary, the hydrogel encapsulation film can not only protect the microneedles and the dissolution pool from contamination, but also, due to its extremely strong adhesion strength, it can make the hydrogel valve tightly adsorbed on the myocardial surface. The strong adhesion pressure makes it easier for the chitosan hollow microneedles to penetrate the myocardial surface, forming a minimally invasive channel and greatly prolonging the residence time of the patch on the myocardial surface.
[0041] The hydrogel substrate contains the nutrients and environment required for stem cells to survive, such as acidity and alkalinity. The hydrogel encapsulation structure allows the patch to stay in the heart for a longer time. The microneedle patch uses the unique advantages of the microneedle patch to deliver stem cells. In the early stage of gelation, the hydrogel can quickly and tightly adhere to the tissue.
[0042] The molten pool at the connection of the hollow microneedle 2 should be made of a base material HPAE-Py / Geln hydrogel. During the working process, the hydrogel patch should be placed in normal saline first, and the hydrogel begins to melt from the vertex when it encounters water. At this time, the flank edges of the encapsulation film 3 encapsulated by the hydrogel also melt at the same time, exposing the hydrogel base material carrying stem cells and the triangular pyramid or cone chitosan microneedle structure. At this time, the doctor can stick the hydrogel microneedle patch to the myocardial necrosis area as the operation proceeds. Due to its excellent adhesion ability, the hydrogel encapsulation film has an adhesion strength of about 22.2kPa to myocardial tissue, which can squeeze the hollow microneedle 2 to puncture the myocardium, so that the stem cells pass through the porous chitosan structure and enter the myocardium from the hollow microneedle 2 ends to achieve the purpose of transporting stem cells.
[0043] As a novel hydrogel cardiac patch, hydrogel has excellent wet adhesion and similar electrical conductivity to myocardium, which is the key to effectively treat myocardium.
[0044] In summary, the present invention discloses a hydrogel microneedle device with higher transport efficiency, stem cell survival rate, healing ability and myocardial repair ability, which is used to transport ventricular myocardial cells with biological activity and function, and can significantly enhance the effect of auxiliary myocardial therapy.
[0045] The above are only preferred specific implementation modes of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical solutions and inventive concepts of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A hydrogel microneedle patch with the function of transporting myocardial stem cells, characterized in that: include: A stem cell lysis pool, the inner wall of which is provided with hydrogel, and the hydrogel is used to encapsulate myocardial stem cells and nutrients that maintain the survival of myocardial stem cells; A plurality of hollow microneedles are arranged in a circle on the top of the stem cell lysate pool and are perpendicular to the substrate of the stem cell lysate pool; the substrate is a concave structure, and the plurality of hollow microneedles arranged in a circle are gathered at one point, providing a channel for myocardial stem cells and nutrients to enter the myocardium; The encapsulation film is arranged around the top of the stem cell lysate pool to encapsulate and wrap the top of the stem cell lysate pool and the hollow microneedles as a whole, and provide sufficient adsorption force for the hydrogel microneedle patch to ensure that the hydrogel microneedle patch will not fall off or be contaminated, and has excellent wet adhesion and electrical conductivity similar to that of the myocardium.
2. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 1, characterized in that: The stem cell lysis pool comprises a substrate, a surrounding plate and a bottom plate, wherein the surrounding plate is erected to form a circle; the substrate is arranged on the top of the surrounding plate, and the bottom plate is arranged at the bottom of the surrounding plate; the hollow microneedles are arranged in a circle on the substrate; The encapsulation film is connected around the enclosure to encapsulate and wrap the hollow microneedles and the substrate.
3. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 1, characterized in that: The hollow microneedle is a shell-like porous structure made of chitosan, and each hollow microneedle is perpendicular to the substrate; the substrate is a plate-like structure made of chitosan, and the substrate is designed to have a concave structure similar to a "concave lens" with a certain concave curvature, which increases the contact area between the hollow microneedle and the myocardial surface, and gathers them in a fixed area in a targeted manner for point-to-point delivery.
4. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 3, characterized in that: The hollow microneedles are arranged in a circular pattern, and each hollow microneedle is perpendicular to the inner side of the concave substrate, so that a number of hollow microneedles are gathered at a "point"; the surrounding plate is a cylindrical structure made of chitosan, and the bottom of the inner wall of the stem cell hydrogel adopts an arc chamfer transition to form an arc chamfered inner wall to reduce the residual myocardial cell solution.
5. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 1, characterized in that: The hollow microneedle is made of chitosan. As time goes by, the chitosan microneedle will gradually melt to form a channel, increasing the speed at which myocardial stem cells enter the myocardium.
6. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 2, characterized in that: The connection between the enclosure and the base plate is arranged as a stepped connection.
7. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 1, characterized in that: The height of the hollow microneedle is 0.5 to 4 mm, the needle body is in the shape of a cone, a triangular pyramid or a quadrangular pyramid, the diameter of the needle tip is 50 to 100 μm, and the size of the bottom end of the needle body is 200 to 500 μm; the porous structure on the needle body is composed of 20 to 50 μm array holes distributed on the side wall of the shell-like structure, and the shell wall thickness is 500 to 800 μm.
8. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 2, characterized in that: The substrate and the surrounding plate are integrally formed with the hollow microneedle; the thickness of the substrate is 300-500 μm; the thickness of the surrounding plate is 500-1000 μm.
9. The hydrogel microneedle patch with the function of transporting myocardial stem cells according to claim 1, characterized in that: The packaging film is a petal-like structure made of a hydrophilic hydrogel material with wet adhesion and electrical conductivity similar to that of the myocardium, which is thick in the middle and thin on both sides. The petal-like structure can completely cover the stem cell lysate pool and the hollow microneedles. The sealed packaging film has a preset built-in stress inside to make the packaging film airtight.
10. An operation method of a hydrogel microneedle patch with the function of transporting myocardial stem cells based on any one of claims 1-9, comprising the following processes: a certain internal stress is preset inside a sealed packaging film to make the packaging film sealed; the packaging film is connected to a substrate to completely cover the stem cell molten pool and the hollow microneedles; after the hydrogel microneedle patch is placed in physiological saline, it gradually dissolves from the apex and the valve flanks and unfolds to expose the internal microneedle structure; the packaging film is composed of pyrrole-terminated poly (β-amino acid) and gelatin; the gradually dissolved hydrogel valve is adsorbed on the myocardial surface, and the hollow microneedle is penetrated into the myocardial surface based on the adhesion pressure to form a minimally invasive channel; the myocardial stem cells are allowed to enter the myocardium from the hollow microneedle end, so as to achieve the purpose of transporting myocardial stem cells and prolong the residence time of the hydrogel microneedle patch on the myocardial surface based on the packaging film that has not been completely melted.
